全文获取类型
收费全文 | 3348598篇 |
免费 | 229376篇 |
国内免费 | 8696篇 |
专业分类
耳鼻咽喉 | 46334篇 |
儿科学 | 111352篇 |
妇产科学 | 92480篇 |
基础医学 | 471495篇 |
口腔科学 | 92611篇 |
临床医学 | 303169篇 |
内科学 | 648863篇 |
皮肤病学 | 80629篇 |
神经病学 | 271744篇 |
特种医学 | 130145篇 |
外国民族医学 | 933篇 |
外科学 | 500209篇 |
综合类 | 66224篇 |
现状与发展 | 6篇 |
一般理论 | 1195篇 |
预防医学 | 250538篇 |
眼科学 | 76383篇 |
药学 | 250003篇 |
13篇 | |
中国医学 | 7307篇 |
肿瘤学 | 185037篇 |
出版年
2021年 | 25685篇 |
2019年 | 26376篇 |
2018年 | 37719篇 |
2017年 | 29226篇 |
2016年 | 34047篇 |
2015年 | 38159篇 |
2014年 | 51752篇 |
2013年 | 77328篇 |
2012年 | 103687篇 |
2011年 | 109292篇 |
2010年 | 65721篇 |
2009年 | 62403篇 |
2008年 | 101981篇 |
2007年 | 108863篇 |
2006年 | 110688篇 |
2005年 | 106590篇 |
2004年 | 102298篇 |
2003年 | 98777篇 |
2002年 | 95359篇 |
2001年 | 161417篇 |
2000年 | 165363篇 |
1999年 | 139381篇 |
1998年 | 39675篇 |
1997年 | 35113篇 |
1996年 | 35177篇 |
1995年 | 33969篇 |
1994年 | 30921篇 |
1993年 | 28991篇 |
1992年 | 107251篇 |
1991年 | 103263篇 |
1990年 | 100455篇 |
1989年 | 97172篇 |
1988年 | 88751篇 |
1987年 | 86719篇 |
1986年 | 81577篇 |
1985年 | 77639篇 |
1984年 | 57650篇 |
1983年 | 48613篇 |
1982年 | 28649篇 |
1979年 | 51203篇 |
1978年 | 35745篇 |
1977年 | 30968篇 |
1976年 | 28149篇 |
1975年 | 30626篇 |
1974年 | 35874篇 |
1973年 | 34264篇 |
1972年 | 32360篇 |
1971年 | 30091篇 |
1970年 | 27681篇 |
1969年 | 26673篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Sebastian Bonner Thomas Matte Mitchell Rubin Joanne K Fagan Jennifer Ahern David Evans 《The Journal of asthma》2006,43(1):31-35
Although studies have documented underuse of controller medications and overuse of short-acting inhaled ss(2)-agonist among children with persistent asthma in disadvantaged communities, the persistence of oral ss(2)-agonist use in pediatric practice has not been studied since inhaled short-acting ss(2)-agonists became widespread. We describe medications used to treat asthma among children 3 to 5 years of age at 10 Head Start and other subsidized preschool centers in East and Central Harlem, New York City. We interviewed 149 parents/guardians of children who were identified as having probable asthma based on physician's diagnosis, persistent symptoms, hospitalization, and medication use. We classified 86 of the 149 children (58%) as having current persistent asthma. Only 15 of them (17%) were reported to have used controller medications at least 5 days/week in the last 4 weeks-only 2 of whom used inhaled corticosteroids. By contrast, 53 children (62%) used oral ss(2)-agonist in the last 4 weeks, often (72%) in conjunction with nebulized or inhaled short-acting ss(2)-agonist. Use of oral ss(2)-agonist was associated with more severe symptoms. This study documents the continued widespread use of oral ss(2)-agonist for treatment of children in a low-income community with high prevalence of asthma. 相似文献
52.
53.
54.
TG Berger F Kiesewetter C Maczek N Bauer M Lueftl G Schuler M Simon Jr 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):178-183
Vitiligo and psoriasis are both common skin disorders. However, psoriasis strictly confined to pre-existing vitiligo areas is rare and suggests a causal relationship. We report here on two patients with a strict anatomical colocalization of vitiligo and psoriasis. The histopathological examinations showed typical changes for both diseases together with a dense infiltrate of CD4+ and CD8+ T cells. By immunohistochemistry, intracytoplasmatic granzyme B and tumour necrosis factor alpha (TNF-alpha) were detected within the T-cell population, suggesting the functional activity of these cells and the creation of a local T helper 1 (Th1)-cytokine milieu. Additionally, in one patient we could identify anti-melanocytic T cells by tetramer staining and enzyme-linked immunospot (ELISPOT) analysis. These skin-infiltrating lymphocytes might trigger, by the local production of Th-1 cytokines such as TNF-alpha and interferon-gamma (IFN-gamma), the eruption of psoriatic plaques in patients with a genetic predisposition for psoriasis. 相似文献
55.
56.
OLG München 《MedR Medizinrecht》2006,24(7):431-433
Abstrakt 1. Ein nicht ausgefülltes und nicht unterschriebenes Aufkl?rungsformular in der Krankenakte bildet ein Indiz nicht für, sondern
gegen die Durchführung eines Aufkl?rungsgespr?chs.
2. Wenn vor dem ?rztlichen Eingriff überhaupt keine Aufkl?rung erfolgt, genügt für den Beginn der Verj?hrung eines auf eine
Aufkl?rungspflichtverletzung gestützten Anspruchs die Kenntnis vom Eintritt schwerwiegender Komplikationen. Nicht erforderlich
ist das Wissen, dass sich ein typisches Risiko des Eingriffs verwirklicht hat. 相似文献
57.
58.
59.
A M Carella 《Leukemia》2003,17(6):1199-1200
60.
Johannes Brettschneider Axel Petzold Sigurd D Süssmuth Georg B Landwehrmeyer Albert C Ludolph Jan Kassubek Hayrettin Tumani 《Movement disorders》2006,21(12):2224-2227
We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH(SMI35) in the laboratory-supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple-system atrophy (MSA; n = 21), progressive supranuclear palsy (PSP; n = 21), corticobasal degeneration (CBD; n = 6), and age-matched controls (n = 45) were included. CSF levels of NfH(SMI35) were measured using ELISA. Levels of CSF NfH(SMI35) were elevated in PSP compared to PD and controls (P < 0.05 each). They were also significantly higher in MSA than in PD and controls (P < 0.05 each). NfH(SMI35) differentiated PD from PSP with a sensitivity of 76.5% and a specificity of 94.4%. Axonal damage as measured by CSF NfH(SMI35) is most prominent in the more rapidly progressive syndromes PSP and MSA as compared to PD or CBD. CSF NfH(SMI35) may therefore be of some value for the laboratory-supported differential diagnosis of atypical parkinsonian syndromes. 相似文献